Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mallinckrodt ARD LLC
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Had a clinical diagnosis of relapsing-remitting multiple sclerosis (RRMS)
Had a relapse with onset ≤42 days prior to the Baseline Visit
Had started treatment with 3 to 5 days (inclusive, over a period of up to 7 days) of specific high dose corticosteroids within 28 days of the onset of the first relapse symptom
Had failed to obtain improvement of at least 1 point in one or more functions on the Function Systems Score (FSS) 14 days following their first dose of high dose corticosteroids
Has an Expanded Disability Index Scale (EDSS) score of 2.0 to 6.5 (inclusive) at the Baseline Visit
Clareo Health | Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)
